DSIJ Mindshare

Multibagger stock at Rs 129 hit upper circuits & 52-week high as company received first ever export order from PARASMANI INC, Canada
Kiran Shroff
/ Categories: Trending, Multibaggers

Multibagger stock at Rs 129 hit upper circuits & 52-week high as company received first ever export order from PARASMANI INC, Canada

The stock gave multibagger returns of 600 per cent in just 1 year and a whopping 3,150 per cent in 5 years.

Mini Diamonds India Ltd (MDIL) has made a significant breakthrough in its international expansion by securing its inaugural export order for 2,000 pieces of lab-grown diamond studded 14KT gold jewellery to Parasmani Inc., a well-established Canadian wholesale jewellery company. This strategic partnership not only marks MDIL's entry into the North American market but also highlights the growing demand for sustainable and ethically sourced lab-grown diamonds in the global jewellery industry.

On Wednesday, shares of Mini Diamonds (India) Ltd were locked in a 2 per cent upper circuit to Rs 129 per share from its previous closing of Rs 126.50. The stock also made a 52-week high is Rs 129 while its 52-week low is Rs 17. The company has a market cap of Rs 46.04 crore.

About the Company

Mini Diamonds, a public limited company established in 1987, has a strong track record in the diamond import and export business. With its state-of-the-art manufacturing facility in Mumbai equipped with advanced technology, Mini Diamonds excels in cutting and polishing diamonds, ensuring precision and quality at every stage. The company also manufactures exquisite lab-grown diamond jewellery, catering to both domestic and international markets through B2B and B2C channels. Mini Diamonds' commitment to innovation, craftsmanship, and strategic marketing positions it as a leader in the lab-grown diamond industry, offering exceptional value and beauty to customers worldwide.

DSIJ’s ‘Micro Marvel' service recommends micro-cap stocks with the potential to grow multifold in long run. If this interests you, do download the service details here.

Revenue from operations for the period surged by 266.5 compared to Q1FY24, escalating from Rs 2.43 crore to Rs 89.13 crore in Q1FY25. EBITDA followed suit, skyrocketing by 578.33 per cent from Rs 0.34 crore to Rs 1.97 crore. This stellar performance is further accentuated by a remarkable 1272.55 per cent growth in PBT/PAT, jumping from Rs 0.14 crore to Rs 1.84 crore. These exceptional results translate to an estimated annualized quarterly EPS of Rs 20.60.

The shares of the company have a PE of 12x and an ROE of 30 per cent. The stock gave multibagger returns of 600 per cent in just 1 year and a whopping 3,150 per cent in 5 years. Investors should keep an eye on this micro-cap stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

Also Read: Ashish Kacholia bought 10,45,750 shares of this multibagger penny stock under Rs 70; Scrip hit 10 per cent upper circuit on September 11

Previous Article Rs 32,500 crore order book: Smart prepaid meters manufacturer incorporates 2 new subsidiaries for power infrastructure and distribution business
Next Article 1:150 bonus share record date announced: Debt-free penny stock under 2 to keep under radar; Earlier bagged order of Rs 61,43,42,414 from Reliance Industries Ltd
Print
39 Rate this article:
5.0
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR